Uganda targets domestic HIV cure production via Cana
Uganda has partnered with Canadian institutions to develop and manufacture HIV cure technologies domestically. This initiative, called Immune Equity, aims to shift Uganda from a recipient of global health innovations to a producer of affordable biomedical solutions.
Why it matters
Localizing the production of advanced medical treatments is a key strategy for improving healthcare equity and accessibility in developing nations.
Health: Uganda targets domestic HIV cure production via Cana
Uganda targets domestic HIV cure production via Canada research
The commitment was announced at a Uganda-Canada partnership side event on advancing HIV cure research, health innovation, and industrial capacity, a hybrid event in Canada on July 14.
ganda plans to manufacture future HIV cure technologies through a new research partnership with Canadian institutions, marking a shift from being primarily a recipient of global health innovations to becoming a developer and producer of advanced biomedical technologies.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in